Patients can already access the first GLP-1 obesity pill from Novo Nordisk, and a rival oral drug from Eli Lilly is slated for U.S. approval later this year.
Is this your feed? Claim it!
Patients can already access the first GLP-1 obesity pill from Novo Nordisk, and a rival oral drug from Eli Lilly is slated for U.S. approval later this year.
Men’s makeup is shedding stigma as TikTok and Gen Z drives growth, retailers rethink displays and brands chase one of beauty’s last untapped markets.
The decision is an about-face for the automaker, which has touted its sales leadership of the models, known as PHEVs, for years.
Eligible customers with insurance can pay as little as $25 for a one-month supply of the drug, while cash-paying options start at $149 a month, Amazon said.
Strong market returns and the AI boom have meant new riches for some employees, but it's risky to have too much of your net worth tied up in one stock.